Bristol Myers Squibb Canada (BMS) today announced that Canada's Drug Agency (CDA-AMC) has issued a positive reimbursement recommendation for OPDIVO® (nivolumab) in combination with YERVOY® (ipilimumab ...

San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...

This initiative marks among the BMS Foundation’s first grants in India to increase access to screening and build capacity to ...

As the digital world surges forward, data centers have become the silent engines powering our daily lives—but at a steep ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

Australia is at a new frontier of property and infrastructure investment, one in which investors don’t require sweeping views ...

Detailed price information for Aerovironment Inc (AVAV-Q) from The Globe and Mail including charting and trades.

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

Neurocrine Biosciences, Inc. ( NBIX) Discusses Progress and Strategy in Neurology and Obesity R&D Programs December 16, 2025 12:00 PM EST ...

ASH Annual Meeting and Exposition leaves the oncology community buzzing over a series of late-breaking presentations that experts are calling 'unprecedented.' Major pharmaceutical developers such as ...

Citius Oncology entered into an exclusive distribution agreement with Er-Kim to expand international access to Lymphir (denileukin diftitox-cxdl) in Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia ...

The electric vehicle (EV) revolution is reshaping the way we move and use energy. As a growing fleet of battery-powered vehicles begins connecting to homes and the broader electricity network, they ...